MedTrace Logo

Survival of BCS vs Mx in Asymptomatic Screen-detected NPBC

NCT06103032 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1020

Last updated 2023-10-26

No results posted yet for this study

Summary

We performed this study on a consecutive cohort of women with asymptomatic screen-detected NPBC. The clinicopathological characteristics, 10-year relapse-free survival (RFS) and overall survival (OS) were compared between BCS and Mx patients among different subgroups.

Conditions

Interventions

PROCEDURE

Breast Conserving Surgery

Patients undergoing breast conserving surgery

PROCEDURE

Mastectomy

Patients undergoing mastectomy

Sponsors & Collaborators

  • Peking Union Medical College Hospital

    lead OTHER

Principal Investigators

  • Qiang SUN, Dr. · Peking Union Medical College Hospital

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2022-12-31
Completion
2023-10-01

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06103032 on ClinicalTrials.gov